NCT01120821View on ClinicalTrials.gov

Treatment of Polycythemia Vera With Gleevec

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

January 31, 2007

Study Completion Date

June 30, 2007

Conditions
Polycythemia Vera
Interventions
DRUG

Gleevec

400 mg once daily for 12 months

Trial Locations (1)

10021

Weill Cornell Medical College, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT01120821 - Treatment of Polycythemia Vera With Gleevec | Biotech Hunter | Biotech Hunter